HB 309 Delaware House · 151st General Assembly (2021-2022)

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE PROVISION OF INFORMATION ABOUT LYME DISEASE.

Summary
This Act, modeled on similar laws in Virginia and Maryland, requires a health-care provider to provide notice to a patient at the time blood is drawn to perform a laboratory test for Lyme disease that explains the limitations of the test and instructs the patient to see their health-care provider if the patient continues to experience unexplained symptoms. This Act was previously passed by the 150th General Assembly in Senate Bill 15, and is the same except for the removal of the sunset provision.
Bill status signed all 5 stages cleared
Introduction
Mar 2022
Committee Review
Apr 2022
House Passage
Mar 2022
Senate Passage
Jun 2022
Signed into Law
Aug 2022
Introduced Mar 3, 2022 Signed Aug 4, 2022
Floor votes · Senate Jun 30, 2022 · House Mar 17, 2022

How they voted

200
Passed
Total votes 20
Jun 30, 2022
D Democratic13
13 Yea
100% Yea
R Republican7
7 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
7
Key actions
5
Committee
2
Aug 4, 2022
Signed into law
Signed by Governor
executive
Jun 30, 2022
Upper · Passed
Passed By Senate. Votes: 21 YES
upper
Apr 6, 2022
Upper · Passed
Reported Out of Committee (Health & Social Services) in Senate with 5 Favorable, 1 On Its Merits
upper
Mar 17, 2022
Introduced
Assigned to Health & Social Services Committee in Senate
upper
Mar 17, 2022
Lower · Passed
Passed By House. Votes: 41 YES
lower
Mar 16, 2022
Lower · Passed
Reported Out of Committee (Health & Human Development) in House with 9 Favorable, 3 On Its Merits
lower
Mar 3, 2022
Introduced
Introduced and Assigned to Health & Human Development Committee in House
lower
5 primary · 20 co-sponsors

Sponsors